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ABSTRACT 
Invasive fungal diseases (IFDs) are severe conditions affecting immunocompromised 
patients. The primary aim of this thesis was to explore different methods for diagnosis 
of IFD in different groups of immunocompromised patients. Papers I and II included 
patients with hematologic disorders. Paper I was a retrospective study evaluating two 
years of serial 1,3-β-d-glucan (betaglucan) testing. Paper II was a prospective study 
where samples were collected for the analysis of betaglucan, galactomannan, bm-
gliotoxin (serum) and D-arabinitol/L-arabinitol (urine). The sensitivity of betaglucan 
and galactomannan was low early in the time course of IFD. The highest positive 
predictive value of betaglucan was obtained when using a cut-off level of at least 160 
pg/ml and when testing patients upon clinical suspicion of IFD. Admission to ICU, 
previous administration of blood products and high serum triglyceride levels were 
associated with elevated betaglucan levels in patients without IFD. Betaglucan levels 
>800 pg/ml were highly indicative of IFD. Bm-gliotoxin could not be detected in 
patients with invasive aspergillosis. Paper III was a retrospective case-control study 
where frozen serum samples from HIV-infected patients and negative controls were 
analyzed for betaglucan and Pneumocystis PCR. Pneumocystis PCR in serum had a 
very high sensitivity and negative predictive value for the diagnosis of PCP. Paper IV 
was a prospective nationwide study on lung transplant recipients where serum and 
BAL-fluid samples were collected during the first post-transplant year for the analysis 
of betaglucan. Development of bronchiolitis obliterans syndrome (BOS) was assessed 
during a median 4.6 years of follow-up. Fungal colonization or tracheobronchitis had 
no impact on the development of BOS or on all-cause mortality. Betaglucan levels in 
serum were low while betaglucan levels in BAL fluid were elevated in patients with 
fungal tracheobronchitis. To conclude, betaglucan and Pneumocystis PCR in serum 
are useful diagnostic methods for different types of IFD although various issues need 
to be considered in order to determine their clinical applicability. 
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